Lux Biosciences News
Most Popular Lux Biosciences Story
Emerging Drug Developer: Lux Biosciences
Lux banks $50M as it readies new drug launch Lux Biosciences announced this morning that it has wrapped a $50 million Series B, and the CEO says much of that money will be used to launch its first
Read more...Latest Headlines
- February 4, 2010
- October 19, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
